A detailed history of Sbi Securities Co., Ltd. transactions in Neogenomics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,884 shares of NEO stock, worth $19,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,884
Previous 1,662 13.36%
Holding current value
$19,951
Previous $15.8 Million 12.68%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$6.4 - $10.27 $1,420 - $2,279
222 Added 13.36%
1,884 $13.8 Million
Q1 2025

May 01, 2025

BUY
$9.09 - $18.61 $990 - $2,028
109 Added 7.02%
1,662 $15.8 Million
Q4 2024

Feb 05, 2025

BUY
$13.0 - $18.43 $20,189 - $28,621
1,553 New
1,553 $25.6 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.33B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.